<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03140358</url>
  </required_header>
  <id_info>
    <org_study_id>R1359/45/2016</org_study_id>
    <nct_id>NCT03140358</nct_id>
  </id_info>
  <brief_title>The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)</brief_title>
  <official_title>The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Singapore National Eye Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Medical Research Council (NMRC), Singapore</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Singapore National Eye Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study of low dose atropine in preventing the onset and progression of myopia in high risk
      children with pre-myopia or low-myopia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High risk children (with family history of myopia) with low hyperopia or low myopia will be
      randomized to atropine or placebo, with 2 -2.5 year treatment and 1 year washout.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 2017</start_date>
  <completion_date type="Anticipated">May 2, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 2, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized control trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Spherical Equivalent</measure>
    <time_frame>3.5 years</time_frame>
    <description>SE</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Axial Length</measure>
    <time_frame>3.5 years</time_frame>
    <description>AL</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">570</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Premyopia atropine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>On Atropine 0.01%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Premyopia placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>On placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low myopia atropine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>On Atropine 0.01% daily or every other day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low myopia placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>On placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atropine sulfate 0.01%</intervention_name>
    <description>Atropine 0.01%</description>
    <arm_group_label>Premyopia atropine</arm_group_label>
    <arm_group_label>Low myopia atropine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>Premyopia placebo</arm_group_label>
    <arm_group_label>Low myopia placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

          1. One parent with myopia (&lt;-3D in at least one eye)

          2. SE +1.00D to -1.50D

          3. Astigmatism &lt; = 1.50D

          4. Distance vision logMAR 0.2 or better in both eyes

          5. Intraocular pressure of not greater than 21 mmHg

          6. No allergy to atropine, cyclopentolate, proparacaine and benzalkonium chloride

        Exclusion Criteria:

          1. Any eye or systemic disease that affect vision or refractive error

          2. Conditions where topical atropine contraindicated

          3. Previous use of atropine or pirenzepine

          4. Known past/current amblyopia or strabismus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>9 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Audrey Chia</last_name>
    <role>Principal Investigator</role>
    <affiliation>Singapore National Eye Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Su Ann Tay</last_name>
    <phone>+6593395137</phone>
    <email>tay.su.ann@singhealth.com.sg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Singapore eye research institute</name>
      <address>
        <city>Singapore</city>
        <zip>423699</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Audrey Chia</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2017</study_first_submitted>
  <study_first_submitted_qc>May 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2017</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Singapore National Eye Centre</investigator_affiliation>
    <investigator_full_name>Audrey Chia Wei-Lin</investigator_full_name>
    <investigator_title>Adjuct Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atropine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

